• No results found

Bioactive lipids as key regulators in atherosclerosis Bot, M.

N/A
N/A
Protected

Academic year: 2021

Share "Bioactive lipids as key regulators in atherosclerosis Bot, M."

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Citation

Bot, M. (2009, January 15). Bioactive lipids as key regulators in atherosclerosis. Retrieved from https://hdl.handle.net/1887/13407

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the

Institutional Repository of the University of Leiden

(2)

Bioactive Lipids as Key Regulators

in Atherosclerosis

(3)
(4)

Bioactive Lipids as Key Regulators in Atherosclerosis

PROEFSCHRIFT ter verkrijging van

de graad van Doctor aan de Universiteit Leiden, op gezag van Rector Magnificus prof.mr. P.F. van der Heijden,

volgens besluit van het College voor Promoties te verdedigen op donderdag 15 januari 2009

klokke 13.45 uur

door

Martine Bot geboren te Dordrecht

in 1979

(5)

The studies presented in this thesis were supported by grant TSN2004.001 from the Netherlands Thrombosis Foundation and were performed at the Division of Biophar- maceutics, Leiden/Amsterdam Center for Drug Research, Leiden University, Leiden, The Netherlands.

Financial support by the Netherlands Heart Foundation for the publication of this thesis is gratefully acknowledged.

The printing of this thesis was financially supported by:

Leiden/Amsterdam Center for Drug Research Universiteit Leiden

J.E. Jurriaanse Stichting

(6)

Aan mijn ouders aan Eric

(7)

Bot, Martine

Bioactive Lipids as Key Regulators in Atherosclerosis Proefschrift Leiden.

Met literatuur opgave – Met samenvatting in het Nederlands

(8)

Chapter 1 Chapter 2

Chapter 3

Chapter 4 Chapter 5

Chapter 6

Chapter 7

Chapter 8

Chapter 9

Page 9 29

51

67

83

99

113

131

155 167 172 176 178

General Introduction

Lysophospholipids: Two-Faced Mediators in Atherosclerosis

Atherosclerotic Lesion Progression Changes Lysophosphatidic Acid Homeostasis to Favor Its Accumulation

Lipid Cartography of Mouse Atherosclerotic Plaques by Cluster-TOF-SIMS Imaging

Lysophosphatidic Acid Destabilizes Atherosclerotic Plaques in ApoE-/- Mice Partly by Activating Perivascular Mast Cells

LPA Administration Changes Atherosclerotic Plaque Phenotype in ApoE-/- Mice by Affecting Vascular Smooth Muscle Cell Content

FTY720, a Synthetic Sphingosine 1-Phosphate Analogue, Inhibits Development of Atherosclerosis in Low-Density Lipoprotein Receptor Deficient Mice Hematopoietic Sphingosine 1-Phosphate Lyase Deficiency Decreases Atherosclerotic Lesion Development in LDL Receptor Deficient Mice

General Discussion and Perspectives Table of Contents

Nederlandse Samenvatting List of Abbreviations List of Publications Curriculum Vitae

(9)

Referenties

GERELATEERDE DOCUMENTEN

We show here that LPA progressively accumulates in mouse atherosclerotic lesions as well, at concentrations that (particularly at 8 weeks after collar placement when

The spatial information on the distribution pattern of individual plaque constituents presented in this study warrants further research on image mass spectrometry, with TOF-SIMS

Apoptosis at later stages of disease progression is considered deleterious for plaque stability and as mast cell degranulation was reported to promote apoptosis of vas- cular

Objective: Migration and proliferation of dedifferentiated vascular smooth muscle cells (VSMCs) is considered one of the early hallmarks of atherosclerotic lesion de-

Peritoneal macrophages were collected for controls (n=7 mice; Ctrl) or animals treated with FTY720 at low doses (n=8 mice; FTY- LD) or high doses (n=8 mice; FTY-HD).

Assessment of chimerism and S1P levels in hematopoietic Sgpl1 -/- chimeras DNA analysis of bone marrow from Sgpl1 -/- transplanted animals showed >90% re- population of Sgpl1 -/-

Besides its effects on mast cells, LPA mediates multiple cellular processes that are instrumental in atherogenesis, including smooth muscle contraction and prolifera- tion 33-38

In het laatste decennium is gebleken dat lipiden niet alleen bijdragen aan het ziek- teproces door ophoping in de plaque, maar dat bepaalde lipiden, zowel aanwezig in de